ILD-NSCLC-GAP index scoring and staging system for patients with non-small cell lung cancer and interstitial lung disease
- 1 July 2018
- journal article
- research article
- Published by Elsevier in Lung Cancer
- Vol. 121, 48-53
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Chemotherapy for non-small cell lung cancer complicated by idiopathic interstitial pneumoniaOncology Letters, 2012
- The Risk of Cytotoxic Chemotherapy-Related Exacerbation of Interstitial Lung Disease with Lung CancerJournal of Thoracic Oncology, 2011
- The safety and efficacy of weekly paclitaxel in combination with carboplatin for advanced non-small cell lung cancer with idiopathic interstitial pneumoniasLung Cancer, 2011
- Clinical characteristics of acute respiratory deterioration in pulmonary fibrosis associated with lung cancer following anti‐cancer therapyRespirology, 2009
- Pirfenidone in idiopathic pulmonary fibrosisEuropean Respiratory Journal, 2009
- Operative Indications for Lung Cancer with Idiopathic Pulmonary FibrosisThe Thoracic and Cardiovascular Surgeon, 2007
- The IASLC Lung Cancer Staging Project: Proposals for the Revision of the TNM Stage Groupings in the Forthcoming (Seventh) Edition of the TNM Classification of Malignant TumoursJournal of Thoracic Oncology, 2007
- Randomized phase III study of cisplatin plus irinotecan versus carboplatin plus paclitaxel, cisplatin plus gemcitabine, and cisplatin plus vinorelbine for advanced non-small-cell lung cancer: Four-Arm Cooperative Study in JapanAnnals of Oncology, 2006
- Randomized, Multinational, Phase III Study of Docetaxel Plus Platinum Combinations Versus Vinorelbine Plus Cisplatin for Advanced Non–Small-Cell Lung Cancer: The TAX 326 Study GroupJournal of Clinical Oncology, 2003
- Comparison of Four Chemotherapy Regimens for Advanced Non–Small-Cell Lung CancerNew England Journal of Medicine, 2002